RESUMO
The article describes a clinical case of a benign tumor from smooth muscle cells - piloleiomyoma. The incidence of leiomyoma in the skin is 3-5% of all leiomyomas. A 27-year-old patient applied to a medical institution with complaints about an intradermal formation in the ear region that occurred repeatedly within 5 months after surgical treatment. After the first surgical intervention, the patient was consulted in various medical organizations, where the following diagnoses were made: «nodular fasciitis¼, «smooth muscle tumor without signs of malignancy¼ and «non-epithelial spindle cell neoplasm¼. According to ultrasound examination, the formation with dimensions of 11×9×5 mm reached the mastoid process of the temporal bone and was characterized by increased internal blood flow. After surgical removal of the neoplasm, taking into account the difficulties of differential diagnosis, an immunohistochemical study was conducted. An accumulation of smooth muscle cells was detected in the surface layers of the dermis under the epidermis by the immunohistochemical study with the use of the marker SMA. A study on CD34 protein revealed a high density of blood capillaries and the absence of its expression in smooth muscle cells. The proliferative index (Ki-67) and mitotic activity (PHH-3) of cells was also studied. The index of proliferative activity was less than 2%, mitoses were isolated. Thus, the results of immunohistochemical study proved the conclusion of piloleiomyoma.
Assuntos
Fasciite , Leiomioma , Neoplasias Cutâneas , Humanos , Adulto , Leiomioma/diagnóstico , Leiomioma/cirurgia , Leiomioma/química , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/cirurgia , Neoplasias Cutâneas/patologia , Fasciite/metabolismo , Fasciite/patologia , Fasciite/cirurgiaRESUMO
BACKGROUND: The differential diagnosis of endometrial stromal tumor (EST) and uterine cellular leiomyoma (CL) remains a challenge in clinical practice, especially low grade endometrial stromal sarcoma (ESS) and CL, suggesting the need for novel immunomarkers panels for differential diagnosis. Interferon-induced transmembrane protein 1 (IFITM1) is a novel immunomarker for endometrial stromal cells, h-caldesmon is an immunomarker for smooth muscle cells and has a higher specificity than smooth muscle actin (SMA). So this study aimed to evaluate whether IFITM1, cluster of differentiation 10(CD10), SMA, and h-caldesmon are useful biomarker combinations for the differential diagnosis of EST and CL. METHODS: Tissue microarrays were used to detect IFITM1, CD10, SMA, and h-caldesmon immunohistochemical staining in 30 EST and 33 CL cases. RESULTS: The expressions of IFITM1 and CD10 were high in EST (86.7 and 63.3%, respectively) but low in CL (18.2 and 21.2%), whereas those of h-caldesmon and SMA were high in CL (87.9 and 100%) and low in EST (6.9 and 40%). In diagnosing EST, IFITM1 shows better sensitivity and specificity (86.7 and 81.8%, respectively) than CD10 (63.3 and 78.8%). The specificity of h-caldesmon in diagnosing CL was significantly higher (93.1%) than that of SMA (60%). When all four antibodies were combined for the differential diagnosis, the area-under-the-curve (AUC) predictive value was 0.995. The best combination for diagnosing EST was IFITM1 (+) or CD10 (+) and h-caldesmon (-) (sensitivity 86.7%, specificity 93.9%). CONCLUSION: The best combination for diagnosing CL were h-caldesmon (+) and SMA (+) (sensitivity 87.9%, specificity 100%). IFITM1, CD10, SMA, and h-caldesmon are a good combination for the differential diagnosis of EST and CL.
Assuntos
Biomarcadores Tumorais/análise , Neoplasias do Endométrio/diagnóstico , Tumores do Estroma Endometrial/diagnóstico , Leiomioma/diagnóstico , Neoplasias Uterinas/diagnóstico , Actinas/análise , Adulto , Idoso , Antígenos de Diferenciação/análise , Antígenos de Neoplasias/análise , Área Sob a Curva , Proteínas de Ligação a Calmodulina/análise , Diagnóstico Diferencial , Neoplasias do Endométrio/química , Tumores do Estroma Endometrial/química , Feminino , Humanos , Imuno-Histoquímica , Leiomioma/química , Pessoa de Meia-Idade , Músculo Liso/química , Neprilisina/análise , Sensibilidade e Especificidade , Neoplasias Uterinas/químicaRESUMO
Leiomyoma of the nipple and areola is a rare subtype of genital leiomyoma. The etiology of the tumor is not well understood. However, sex hormones like estrogen and progesterone have been implicated in the tumorigenesis. Hereby, we report a 47-year-old man with an estrogen receptor positive, progesterone receptor negative, leiomyoma of the areola.
Assuntos
Neoplasias da Mama Masculina/patologia , Leiomioma/patologia , Neoplasias da Mama Masculina/química , Humanos , Leiomioma/química , Masculino , Pessoa de Meia-Idade , Mamilos/patologia , Receptores de Estrogênio/análise , Receptores de Progesterona/análiseRESUMO
Objective: To study clinical and pathologic characteristics of leiomyomas of the gastrointestinal tract, and to investigate the distribution characteristics of interstitial cells of Cajal ( ICCs ) in gastrointestinal leiomyomas. Methods: One hundred and forty-seven cases of leiomyomas of gastrointestinal tract were collected at the Second Affiliated Hospital of Zhengzhou University from June 2012 to June 2017. Clinical and pathologic findings were analyzed, combined with immunohistochemistry, Alcian blue-osafranin staining and molecular study. Results: The age of patients ranged from 13-82 years with mean age of 52 years. Male to female ratio was about 1â¶2. Histologically, all tumors were composed of ovoid to spindle cells arranged in short intersecting fascicles. All tumors were diffusely and strongly positive for smooth muscle antibodies, desmin and h-caldesmon by immunohistochemical staining. A prominent interspersed subpopulation of elongated/dendritic-like cells with CD117 and DOG1 positivity (accounting for 1% to 30% of all tumor cells) and negative for Alcian blue-osafranin staining was identified in all esophageal leiomyomas, 16 of 20 (80%) gastric leiomyomas and 3 of 12 small bowel leiomyomas, but none in colonic/rectal leiomyomas. Mutational analysis in 16 cases showed absence of mutation in exons 9, 11, 13 or 17 of C-KIT and exons 12 or 18 of PDGFRA. Conclusions: ICCs are identified in esophageal and gastric leiomyomas, as well as in small percentage of intestinal leiomyomas. Such findings may bring significant diagnostic pitfalls for misdiagnosis as gastrointestinal stromal tumor. Careful attention to the distribution of CD117 and DOG1 positive cells and molecular mutation analysis of C-KIT and PDGFRA may be necessary to establish the correct diagnosis.
Assuntos
Neoplasias Gastrointestinais/patologia , Tumores do Estroma Gastrointestinal/patologia , Células Intersticiais de Cajal/patologia , Leiomioma/patologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Anoctamina-1/análise , Proteínas de Ligação a Calmodulina/análise , Neoplasias do Colo/química , Neoplasias do Colo/patologia , Análise Mutacional de DNA , Desmina/análise , Diagnóstico Diferencial , Neoplasias Esofágicas/química , Neoplasias Esofágicas/patologia , Éxons , Feminino , Neoplasias Gastrointestinais/química , Neoplasias Gastrointestinais/genética , Tumores do Estroma Gastrointestinal/química , Tumores do Estroma Gastrointestinal/genética , Humanos , Imuno-Histoquímica , Células Intersticiais de Cajal/química , Leiomioma/química , Leiomioma/genética , Masculino , Pessoa de Meia-Idade , Mutação , Proteínas de Neoplasias/análise , Proteínas Proto-Oncogênicas c-kit/análise , Proteínas Proto-Oncogênicas c-kit/genética , Receptor alfa de Fator de Crescimento Derivado de Plaquetas/genética , Adulto JovemRESUMO
PURPOSE: To evaluate the effects of transforming growth factor-ß (TGF-ß) on uterine fibroids of women of childbearing age and uterine artery embolization (UAE) using Embosphere microspheres. MATERIAL AND METHODS: A total of 128 eligible women were randomly divided into an experimental group and a control group (n = 64) who received UAE using Embosphere microspheres and panhysterectomy, respectively. Another 128 healthy women receiving physical examination in the same period were also enrolled. Serum TGF-ß levels were detected by enzyme-linked immunosorbent assay (ELISA). Serum TGF-ß level, size of uterine fibroid and prognosis were followed up. RESULTS: The serum TGF-ß level of patients was significantly higher than that of healthy subjects. After treatment, the red blood cell counts and hemoglobin levels of the two patient groups significantly increased compared with those before (p < .05). After UAE, the diameter of uterine fibroids was significantly smaller than that before treatment, and the TGF-ß level significantly decreased (p < .05). The expression of TGF-ß in uterine fibroids was significantly higher than that in surrounding normal tissue (p < .05). CONCLUSION: With the uterus retained, the therapeutic effect of UAE was similar to that of panhysterectomy. TGF-ß expression level was associated with growth of uterine fibroid in women of childbearing age, which can be used as a target for treatment.
Assuntos
Leiomioma/sangue , Leiomioma/cirurgia , Fator de Crescimento Transformador beta/sangue , Adolescente , Adulto , Fatores Etários , Feminino , Humanos , Histerectomia , Leiomioma/química , Microesferas , Prognóstico , Fator de Crescimento Transformador beta/análise , Fator de Crescimento Transformador beta/biossíntese , Embolização da Artéria Uterina , Útero/química , Adulto JovemRESUMO
Uterine leiomyomas in miniature pet pigs occur similarly to those in women with regard to frequency, age, parity, and cycling. Clinical signs, gross, and histologic features of the porcine tumors closely resemble uterine leiomyomas (fibroids) in women. Although fibroids are hormonally responsive in women, the roles of estrogen and progesterone have not been fully elucidated. In this study, immunohistochemistry was used to assess the expression of the steroid hormone receptors, estrogen receptor alpha (ER-α), estrogen receptor beta (ER-ß) and progesterone receptor (PR), and cell proliferation markers, proliferating cell nuclear antigen (PCNA) and Ki-67 in tumor and matched myometrial tissues sampled from miniature pigs. A "quickscore" method was used to determine receptor expression and labeling indices were calculated for the markers. ER-α/ß and PR were localized to the nuclei of smooth muscle cells in both tissues. PR expression was intense and diffuse throughout all tissues, with correlation between tumors and matched myometria. Conversely, ER-α expression was variable between the myometrial and tumor tissues, as well as between animals. ER-ß expression was low. PCNA and Ki-67 were localized to the nucleus and expression varied among tumors; however, normal tissues were overall negative. These findings support further investigation into the use of the miniature pig as a model of fibroids in women.
Assuntos
Biomarcadores/metabolismo , Leiomioma , Miométrio , Antígeno Nuclear de Célula em Proliferação/metabolismo , Receptores de Estrogênio/metabolismo , Neoplasias Uterinas , Animais , Biomarcadores/análise , Feminino , Imuno-Histoquímica , Antígeno Ki-67/análise , Antígeno Ki-67/metabolismo , Leiomioma/química , Leiomioma/metabolismo , Leiomioma/patologia , Leiomioma/veterinária , Miométrio/química , Miométrio/metabolismo , Miométrio/patologia , Antígeno Nuclear de Célula em Proliferação/análise , Receptores de Estrogênio/análise , Receptores de Progesterona/análise , Receptores de Progesterona/metabolismo , Suínos , Porco Miniatura , Neoplasias Uterinas/química , Neoplasias Uterinas/metabolismo , Neoplasias Uterinas/patologia , Neoplasias Uterinas/veterináriaRESUMO
BACKGROUND: Benign lesions of the breast in total are much more frequent than malignant ones. However, there are no epidemiologic data on the prevalence of benign or malignant tumours of the nipple, and the bibliography on benign nipple tumours in general is limited. AIMS: To present some rare cases of benign nipple tumours and review the literature. MATERIALS AND METHODS: Four cases of rare benign nipple tumours: neurofibromas, wart, leiomyoma and milium are presented. The literature search on benign nipple tumours was performed using MEDLINE, Pubmed, and Cochrane databases with limits: English language, human species and available abstract. The keyword used was 'benign nipple tumours'. RESULTS: The initial search retrieved 337 articles. The papers were reviewed and the articles that referred to benign lesions that appeared at the nipple specifically were identified. Different entities that were described included: neurofibroma, leiomyoma, milium, florid papillomatosis, syringomatous adenoma, nevoid hyperkeratosis, fibroma, pseudolymphoma and haemangioma. DISCUSSION: Differential diagnosis of benign tumours of the nipple can be demanding for the physicians. Many of the symptoms and signs like pruritus, serosanguinous discharge, lichenification, erosion and nodular enlargement are produced by either malignant or benign nipple lesions. Radiology can be unclear in the diagnosis of nipple abnormalities. CONCLUSION: Histological examination of the lesion can be the only definite answer in these cases.
Assuntos
Neoplasias da Mama/patologia , Leiomioma/patologia , Neurofibromatose 1/patologia , Mamilos , Neoplasias Cutâneas/patologia , Verrugas/patologia , Adulto , Feminino , Humanos , Lactente , Leiomioma/química , Pessoa de Meia-Idade , Miliária/diagnóstico , Papiloma/diagnóstico , Pseudolinfoma/diagnóstico , Doenças Raras , Siringoma/diagnóstico , Verrugas/cirurgiaRESUMO
Leiomyoma is an extremely rare tumor in sinonasal area. The reason for this is due to minimal amount of the smooth muscle in the area. The origin of this tumor is not clear and its etiology has not been proven in the literature. A 58-year-old woman who experienced nasal obstruction and epiphora visited our clinic. A huge mass was noted in right nasal cavity originating from the lacrimal bone area. The authors conducted endoscopic sinus surgery and obtained the specimen. Immunochemistry showed leiomyoma in the nasal cavity, which expressed estrogen receptor. There was no progesterone receptor expressed. The authors describe a sinonasal leiomyoma with estrogen receptors, not ever reported in previous article.
Assuntos
Leiomioma/diagnóstico , Neoplasias Nasais/diagnóstico , Neoplasias dos Seios Paranasais/diagnóstico , Receptores de Estrogênio/análise , Endoscopia/métodos , Feminino , Seguimentos , Humanos , Doenças do Aparelho Lacrimal/diagnóstico , Leiomioma/química , Pessoa de Meia-Idade , Cavidade Nasal/patologia , Obstrução Nasal/diagnóstico , Neoplasias Nasais/química , Neoplasias dos Seios Paranasais/químicaRESUMO
A family of cell adhesion molecules have been associated with tumorigenesis and tumour cell invasion. Cadherins and CD44 isoforms are transmembrane glycoproteins. Uterine smooth muscle tumours range from leiomyomas to leiomyosarcomas. However, separating malignant from benign can be difficult in a subset of smooth muscle tumours. Cell adhesion molecules expression may have diagnostic utility in the distinction of leiomyosarcoma from atypical leiomyoma. The aim of this study was to evaluate the diagnostic tool role of CD44 standard and E-cadherin in atypical leiomyoma and leiomyosarcoma. Paraffin blocks of 35 atypical leiomyoma and 22 leiomyosarcoma were analysed immunohistochemically for the expression CD44 standard and E-cadherin protein. Expression of CD44 standard was positive in all cases, while E-cadherin was negative. In this study, CD44 and E-cadherin were not useful for diagnostic tool to differentiate atypical leiomyoma from leiomyosarcoma.
Assuntos
Caderinas/análise , Receptores de Hialuronatos/análise , Leiomioma/diagnóstico , Leiomiossarcoma/diagnóstico , Neoplasias Uterinas/diagnóstico , Adulto , Idoso , Diagnóstico Diferencial , Feminino , Humanos , Imuno-Histoquímica , Leiomioma/química , Leiomiossarcoma/química , Pessoa de Meia-Idade , Neoplasias Uterinas/químicaRESUMO
Recent identification of somatic MED12 mutations in most uterine leiomyomas brings a new venue for the study of the tumorigenesis of leiomyomas. We are particularly interested in the correlation of MED12 and HMGA2 gene products in leiomyomas and leiomyosarcomas with and without MED12 mutations. To address these issues, in this study we examined MED12 mutations in a large cohort of usual type leiomyomas (178 cases) and uterine leiomyosarcomas (32 cases). We found that 74.7% (133/178) of leiomyomas had MED12 mutations, which was consistent with several independent studies. In contrast, only 9.7% (3/32) of leiomyosarcomas harbored MED12 mutations. Expression analysis by western blot and immunohistochemistry revealed that those leiomyomas with complex MED12 mutations had significantly lower protein products than the matched myometrium. Interestingly, most leiomyosarcomas without MED12 mutations also had very low levels of MED12 expression in comparison to the matched myometrium. These findings suggest a potential functional role of MED12 in both benign and malignant uterine smooth muscle tumors. When we further examined HMGA2 expression in all leiomyomas and leiomyosarcomas, we found that HMGA2 overexpression was exclusively present in those leiomyomas with no MED12 mutation, accounting for 10.1% (18/178) of total leiomyomas and 40% (18/45) of non-MED12 mutant leiomyomas. Twenty-five percent (8/32) of leiomyosarcomas had HMGA2 overexpression, and no MED12 mutations were found in HMGA2 positive leiomyosarcoma. These findings strongly suggest that MED12 mutations and HMGA2 overexpression are independent genetic events that occur in leiomyomas, and they may act differently in the tumorigenesis of uterine leiomyomas.
Assuntos
Biomarcadores Tumorais/análise , Biomarcadores Tumorais/genética , Proteína HMGA2/análise , Leiomioma/genética , Leiomiossarcoma/genética , Complexo Mediador/genética , Mutação , Neoplasias Uterinas/genética , Adulto , Idoso , Idoso de 80 Anos ou mais , Western Blotting , Análise Mutacional de DNA , Feminino , Regulação Neoplásica da Expressão Gênica , Predisposição Genética para Doença , Proteína HMGA2/genética , Humanos , Imuno-Histoquímica , Leiomioma/química , Leiomioma/patologia , Leiomiossarcoma/química , Leiomiossarcoma/patologia , Complexo Mediador/análise , Pessoa de Meia-Idade , Fenótipo , Translocação Genética , Regulação para Cima , Neoplasias Uterinas/química , Neoplasias Uterinas/patologia , Adulto JovemRESUMO
AIM: Growth factors take place in the formation and growth of uterine leiomyomas (LMs). Transforming growth factor beta (TGF-beta), epidermal growth factor (EGF), platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), fibroblast growth factor-2 (FGF-2), and insulin-like growth factor (IGF) contribute to the pathophysiology of LMs when they bind with a specific membrane receptor and transmit a signal into the cell. Little is known about hepatocyte growth factor (HGF) and its receptor system c-Met in formation and growth of uterine LMs. The aim of this study was to evaluate the c-Met receptor expression on human myometrium and uterine LMs. MATERIALS AND METHODS: The study was performed on human myometrium and uterine LMs. Expression of c-Met receptor was evaluated by immunohistochemical analysis. RESULTS: Overexpression of c-Met was found in all LM cases and in none of normal myometrium samples c-Met overexpression was seen. CONCLUSION: HGF and c-Met receptor complex seem to have role in development of uterine LMs.
Assuntos
Leiomioma/química , Miométrio/química , Proteínas Proto-Oncogênicas c-met/análise , Neoplasias Uterinas/química , Adulto , Feminino , Humanos , Pessoa de Meia-IdadeAssuntos
Neoplasias Esofágicas/patologia , Leiomioma/patologia , Neoplasias do Mediastino/patologia , Adulto , Biomarcadores Tumorais/análise , Biópsia , Endoscopia do Sistema Digestório , Endossonografia , Neoplasias Esofágicas/química , Neoplasias Esofágicas/cirurgia , Esofagectomia , Humanos , Imuno-Histoquímica , Leiomioma/química , Leiomioma/cirurgia , Masculino , Neoplasias do Mediastino/química , Neoplasias do Mediastino/cirurgia , Imagem Multimodal , Tomografia por Emissão de Pósitrons , Valor Preditivo dos Testes , Tomografia Computadorizada por Raios X , Carga TumoralRESUMO
Soft-tissue glomus tumours are benign lesions derived from the glomus bodies, which are specialized arteriovenous shunts that serve a thermoregulatory function and are concentrated in the distal extremities of the dermis. Glomangioleiomyoma is rarely found in the orbit, most likely because of the paucity of smooth muscle and glomus bodies in this location. We report the case of a woman with exophthalmos in whom computerized tomography and magnetic resonance imaging showed a large, lobulated mass in the right intraconal space.
Assuntos
Tumor Glômico/patologia , Leiomioma/patologia , Neoplasias Orbitárias/patologia , Actinas/análise , Antígenos CD34/análise , Biomarcadores Tumorais/análise , Feminino , Tumor Glômico/química , Humanos , Leiomioma/química , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade , Neoplasias Orbitárias/química , Molécula-1 de Adesão Celular Endotelial a Plaquetas/análise , Proteínas S100/análise , Tomografia Computadorizada por Raios X , Vimentina/análiseAssuntos
Epididimo/patologia , Neoplasias dos Genitais Masculinos/patologia , Leiomioma/patologia , Biomarcadores Tumorais/análise , Epididimo/cirurgia , Neoplasias dos Genitais Masculinos/química , Neoplasias dos Genitais Masculinos/cirurgia , Humanos , Leiomioma/química , Leiomioma/cirurgia , Masculino , Pessoa de Meia-Idade , OrquiectomiaRESUMO
TP63, a member of the TP53 gene family, is a nuclear marker of myoepithelial cells. Antibody against p63 is frequently used to aid in the diagnosis of prostate carcinoma, as well as in the identification of myoepithelial cells in other tissues including the breast. p63 is also a marker for squamous cell carcinoma. Recently, it was found that all p53 family members are involved in regulating the process of muscle differentiation through the retinoblastoma (RB) protein. Ablation of these p53 family functions blocks the differentiation program and promotes malignant transformation by enabling cooperating oncogenes to transform myoblasts. We therefore studied p63 expression in a number of neoplasms with myogenic differentiation. Immunohistochemical staining for p63 was performed on paraffin sections from 38 rhabdomyosarcomas, five leiomyomas, five leiomyosarcomas, five rhabdomyomas, five rhabdomyomatous Wilms tumors, three normal cardiac muscles, one medullomyoblastoma, one pleuropulmonary blastoma with rhabdomyomatous differentiation, and one teratoma with prominent rhabdomyoblasts. Each case was also stained with desmin. Unlike the nuclear staining scored in myoepithelial cells, only cytoplasmic staining for p63 was considered positive. Of 38 cases of rhabdomyosarcoma, 36 showed cytoplasmic p63 staining; 24 of these showed highlighting of cross-striations superior to that of desmin. In addition, 5/5 rhabdomyomas, 5/5 rhabdomyomatous Wilms tumors, 1/1 pleuropulmonary blastoma with rhabdomyomatous differentiation, 1/1 teratoma with atypical rhabdoblasts, and 1/1 medullomyoblastoma exhibited cytoplasmic p63 staining. Normal cardiac muscle samples (3/3) also demonstrated positive cytoplasmic staining and distinct cross-striations. Smooth muscle tumors exhibited only very focal and faint cytoplasmic staining in 5/5 leiomyomas and 4/5 leiomyosarcomas. Immunoelectron microscopic study of skeletal muscle showed p63 localization to the Z bands of sarcomeres. We conclude that p63 immunostain is a sensitive marker for skeletal muscle differentiation and highlights the cross-striations of strap cells with exceptional definition.
Assuntos
Biomarcadores Tumorais/análise , Diferenciação Celular , Citoplasma/química , Citoplasma/patologia , Imuno-Histoquímica , Microscopia Imunoeletrônica , Músculo Esquelético/química , Músculo Esquelético/patologia , Neoplasias/química , Neoplasias/patologia , Fatores de Transcrição/análise , Proteínas Supressoras de Tumor/análise , Neoplasias Cerebelares/química , Neoplasias Cerebelares/patologia , Citoplasma/ultraestrutura , Humanos , Neoplasias Renais/química , Neoplasias Renais/patologia , Leiomioma/química , Leiomioma/patologia , Leiomiossarcoma/química , Leiomiossarcoma/patologia , Meduloblastoma/química , Meduloblastoma/patologia , Músculo Esquelético/ultraestrutura , Músculo Liso/química , Músculo Liso/patologia , Miocárdio/química , Miocárdio/patologia , Neoplasias/ultraestrutura , Blastoma Pulmonar/química , Blastoma Pulmonar/patologia , Rabdomiossarcoma/química , Rabdomiossarcoma/patologia , Teratoma/química , Teratoma/patologia , Tumor de Wilms/química , Tumor de Wilms/patologiaRESUMO
Deregulated steroids are involved in different hormone-dependent tumors, including benign and malignant uterine neoplasms. Leiomyomas (LM) are estrogen and progesterone-dependent benign tumors, whereas "bizarre or atypical LMs" (AL) are considered a subgroup of LM and clinically benign, although their malignant potential is suspect. Uterine leiomyosarcomas (LMS) are malignant smooth muscle tumors, and ovarian steroids may control their growth. Estrogen effects are mediated by 2 receptors, estrogen receptors (ER) α and ß, and the ratio of both receptors seems to be a critical parameter in the estrogen-mediated carcinogenic process. Estradiol induces the expression of neurotensin (NTS), and the coupling of this peptide with its high-affinity receptor, NTS1, has been involved in the regulation of tumoral cell growth. Given the importance of these markers in tumor development, we aim to determine the status of ERα and ERß in the myometrium and LM, AL, and LMS, concomitantly with the expression of NTS/NTS receptor 1 in these tumors. For that purpose, we use immunohistochemistry for all markers analyzed and in-situ hybridization to detect NTS mRNA. These data suggest that LMS are estrogen-dependent tumors, which may use NTS as an autocrine growth factor. In addition, the phenotype of AL with regard to ERα and ERß status and NTS expression is closer to LMS than LM; thus, a potential malignization of this tumor is feasible.
Assuntos
Receptor alfa de Estrogênio/análise , Receptor beta de Estrogênio/análise , Leiomioma/química , Leiomiossarcoma/química , Neurotensina/análise , Neoplasias Uterinas/química , Núcleo Celular/química , Feminino , Humanos , Imuno-Histoquímica , Hibridização In Situ , Músculo Liso/química , Músculo Liso/ultraestrutura , Miométrio/química , Receptores de Neurotensina/análiseRESUMO
The purpose of this study was to determine the value of electrical conductivity that can be used for numerical modelling in vivo radiofrequency ablation (RFA) treatments of human uterine fibroids. No experimental electrical conductivity data have previously been reported for human uterine fibroids. In this study electrical data (voltage) from selected in vivo clinical procedures on human uterine fibroids were used to numerically model the treatments. Measured versus calculated power dissipation profiles were compared to determine uterine fibroid electrical conductivity. Numerical simulations were conducted utilising a wide range of values for tissue thermal conductivity, heat capacity and blood perfusion coefficient. The simulations demonstrated that power dissipation was insensitive to the exact values of these parameters for the simulated geometry, treatment duration, and power level. Consequently, it was possible to determine tissue electrical conductivity without precise knowledge of the values for these parameters. Results of this study showed that an electrical conductivity for uterine fibroids of 0.305 S/m at 37°C and a temperature coefficient of 0.2%/°C can be used for modelling Radio Frequency Ablation of human uterine fibroids at a frequency of 460 kHz for temperatures from 37°C to 100°C.
Assuntos
Condutividade Elétrica , Leiomioma/química , Leiomioma/patologia , Modelos Biológicos , Neoplasias Uterinas/química , Neoplasias Uterinas/patologia , Ablação por Cateter/instrumentação , Ablação por Cateter/métodos , Simulação por Computador , Feminino , Humanos , Leiomioma/cirurgia , Temperatura , Neoplasias Uterinas/cirurgiaRESUMO
OBJECTIVE: Although fibroids greatly affect reproductive health, the pathophysiology and epidemiology are not well known. Recently, we have reported the relationship between uterine leiomyoma and metabolic syndrome. Many studies have indicated that reductions in plasma adiponectin levels play major roles in the development of metabolic syndrome. In this study, we investigated the significant repressive effect of adiponectin on rat uterine leiomyoma ELT-3 cells proliferation. STUDY DESIGN: Expression of adiponectin receptor 1 and receptor 2 was evaluated by RT-PCR and Western blot analysis. Cell proliferation was assessed by the MTS assay and cell counting. Apoptosis was evaluated by Hoechst staining and cleaved poly (ADP-ribose) polymerase (PARP). RESULTS: Adiponectin receptor 1 and receptor 2 were expressed in ELT-3 cells. Adiponectin repressed rat uterine leiomyoma ELT-3 cells cell proliferation without inducing apoptosis. CONCLUSION: The repression of adiponectin on leiomyoma cell proliferation in the rat may explain a crucial role of adiponectin in the association of metabolic syndrome with uterine leiomyoma.
Assuntos
Adiponectina/farmacologia , Divisão Celular/efeitos dos fármacos , Leiomioma/patologia , Neoplasias Uterinas/patologia , Animais , Apoptose , Linhagem Celular Tumoral , Feminino , Expressão Gênica/efeitos dos fármacos , Leiomioma/química , RNA Mensageiro/análise , Ratos , Receptores de Adiponectina/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Neoplasias Uterinas/químicaRESUMO
Four myxoid variant of uterine mesenchymal tumors are reported. One was a low grade stromal sarcoma with infiltrative margins and the others were well circumscribed tumors corresponding to an endometrial stromal nodule and two leiomyomas. They were hypocellular neoplasms composed of stellated cells with an abundant Alcian Blue positive myxoid matrix. The myxoid nature of the neoplasms obscured their cellular nature and made the distinction between smooth muscle and endometrial stromal tumors difficult. Endometrial stromal tumors, showed very focal areas of small basophilic cells, characteristic of endometrial stroma. The diagnosis was based on the presence of a spiral arteriolar network, a CD10 positivity as well as the absence of h-caldesmon and desmin expression. The two myxoid leiomyomas showed more spindle cells and a desmin expression while h-caldesmon was negative and CD10 focally positive in both cases. Myxoid variant of endometrial stromal tumors does not necessarily exhibit the typical morphology of endometrial stroma. They may demonstrate morphological features of smooth muscle tumors in the uterus. Also, myxoid changes in uterin smooth muscle tumors may modify the classical immunoreactivity of smooth muscle markers in these tumors and make it difficult to distinguish between benign and malignant neoplasms. An immunohistochemical panel of antibodies including CD10, h-caldesmon and desmin may help in establishing the correct diagnosis.